Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$86.26 - $119.0 $22,513 - $31,059
-261 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$100.17 - $126.36 $15,626 - $19,712
156 Added 148.57%
261 $29,000
Q2 2021

Jul 22, 2021

SELL
$86.05 - $119.72 $2,581 - $3,591
-30 Reduced 22.22%
105 $12,000
Q1 2021

Apr 20, 2021

BUY
$91.47 - $124.36 $5,305 - $7,212
58 Added 75.32%
135 $14,000
Q4 2020

Feb 02, 2021

SELL
$66.66 - $111.74 $3,466 - $5,810
-52 Reduced 40.31%
77 $8,000
Q3 2020

Oct 15, 2020

BUY
$45.89 - $72.67 $5,919 - $9,374
129 New
129 $9,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Evolution Wealth Advisors, LLC Portfolio

Follow Evolution Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.